Data as of Sep 21, 2026 · Based on 3,332,371 AI responses across 10,526 prompts · See how Parse measures this
Valar Labsvalarlabs.comValar Labs develops AI-powered cancer diagnostics that analyze solid tumor tissue to predict how patients will respond to specific therapies, delivering actionable reports to guide physician and patient decisions. Its Vesta product predicts bladder cancer patients' response to BCG using routine histology, and the company is expanding with Vitara and CHAI-powered biomarkers to forecast responses in other cancers such as prostate cancer. Valar Labs partners with pharmaceutical companies to accelerate R&D and reduce uncertainty in therapy selection, supported by funding and clinical validation.
Parse Score
No contexts measured yet.
Excerpts where Valar Labs appeared in the AI's answer
Valar Labs — Uses AI on routine pathology to predict how an individual tumor is likely to respond to specific treatments.
Valar Labs — Uses AI on tumor pathology to predict how a particular cancer is likely to respond to therapy.
